×




Boehringer Ingelheim: Leading Innovation Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Boehringer Ingelheim: Leading Innovation case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Boehringer Ingelheim: Leading Innovation case study is a Harvard Business School (HBR) case study written by J. Robert Mitchell, Chandra Sekhar Ramasastry. The Boehringer Ingelheim: Leading Innovation (referred as “Boehringer Ingelheim” from here on) case study provides evaluation & decision scenario in field of Strategy & Execution. It also touches upon business topics such as - Value proposition, Competition.

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of Boehringer Ingelheim: Leading Innovation Case Study


The newly appointed director of Innovation Management & Strategy at Boehringer Ingelheim, a German-based multinational pharmaceutical company, is finding his way forward in his firm's new, first-of-its-kind role, which is central to the company's growth rejuvenation strategy. His job has a threefold mandate: to build internal networks, to establish internal structures and to leverage internal ideas. His biggest challenge, however, may be transforming the organization's DNA. The blockbuster business model that has characterized the company for decades is no longer appropriate. Instead, the firm needs to develop healthcare products available to end users over the counter. This shift in strategy requires innovative changes in distribution, delivery and customer focus. To accomplish this goal, he needs to institutionalize innovation so that it becomes sustainable. But in doing so, he must also identify the metrics for assessing progress. The case provides an opportunity for students to step into the shoes of an innovation leader, to develop an innovation roadmap for the organization in the face of uncertainty and to understand how to engage in innovation leadership at various levels of a global enterprise.


Case Authors : J. Robert Mitchell, Chandra Sekhar Ramasastry

Topic : Strategy & Execution

Related Areas : Competition




Calculating Net Present Value (NPV) at 6% for Boehringer Ingelheim: Leading Innovation Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10010192) -10010192 - -
Year 1 3472311 -6537881 3472311 0.9434 3275765
Year 2 3956493 -2581388 7428804 0.89 3521265
Year 3 3945151 1363763 11373955 0.8396 3312425
Year 4 3241156 4604919 14615111 0.7921 2567299
TOTAL 14615111 12676754




The Net Present Value at 6% discount rate is 2666562

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Payback Period
2. Net Present Value
3. Profitability Index
4. Internal Rate of Return

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Timing of the expected cash flows – stockholders of Boehringer Ingelheim have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.
2. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Boehringer Ingelheim shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.






Formula and Steps to Calculate Net Present Value (NPV) of Boehringer Ingelheim: Leading Innovation

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Strategy & Execution Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Boehringer Ingelheim often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Boehringer Ingelheim needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10010192) -10010192 - -
Year 1 3472311 -6537881 3472311 0.8696 3019401
Year 2 3956493 -2581388 7428804 0.7561 2991677
Year 3 3945151 1363763 11373955 0.6575 2594001
Year 4 3241156 4604919 14615111 0.5718 1853141
TOTAL 10458220


The Net NPV after 4 years is 448028

(10458220 - 10010192 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10010192) -10010192 - -
Year 1 3472311 -6537881 3472311 0.8333 2893593
Year 2 3956493 -2581388 7428804 0.6944 2747565
Year 3 3945151 1363763 11373955 0.5787 2283073
Year 4 3241156 4604919 14615111 0.4823 1563057
TOTAL 9487288


The Net NPV after 4 years is -522904

At 20% discount rate the NPV is negative (9487288 - 10010192 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Boehringer Ingelheim to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Boehringer Ingelheim has a NPV value higher than Zero then finance managers at Boehringer Ingelheim can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Boehringer Ingelheim, then the stock price of the Boehringer Ingelheim should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Boehringer Ingelheim should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

What can impact the cash flow of the project.

Understanding of risks involved in the project.

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

What will be a multi year spillover effect of various taxation regulations.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of Boehringer Ingelheim: Leading Innovation

References & Further Readings

J. Robert Mitchell, Chandra Sekhar Ramasastry (2018), "Boehringer Ingelheim: Leading Innovation Harvard Business Review Case Study. Published by HBR Publications.


Stuart Olson SWOT Analysis / TOWS Matrix

Capital Goods , Construction Services


Namaste Techn SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs


Tianshan Wool A SWOT Analysis / TOWS Matrix

Basic Materials , Metal Mining


Kyocera ADR SWOT Analysis / TOWS Matrix

Technology , Electronic Instr. & Controls


Perpetual Income SWOT Analysis / TOWS Matrix

Financial , Misc. Financial Services


Derichebourg SWOT Analysis / TOWS Matrix

Services , Waste Management Services


Synchro Food SWOT Analysis / TOWS Matrix

Technology , Computer Services


American Green SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs


Advicenne SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs


Yongtai Tech A SWOT Analysis / TOWS Matrix

Basic Materials , Chemical Manufacturing